« Previous
Next »
Journal of Clinical Anesthesia
Volume 21, Issue 7
, Pages 493-501
, November 2009
Comparison of patient-controlled analgesia with and without dexmedetomidine following spine surgery in children
References
- . Characterization of the selectivity, specificity and potency of medetomidine as an alpha 2-adrenoceptor agonist. Eur J Pharmacol. 1988;150:9–14
- . Dexmedetomidine: applications in pediatric critical care and pediatric anesthesiology. Pediatr Crit Care Med. 2007;8:115–131
- . The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology. 2000;93:382–394
- . The analgesic action of dexmedetomidine–a novel alpha 2-adrenoceptor agonist–in healthy volunteers. Pain. 1991;46:281–285
- . Effect of intravenously administered dexmedetomidine on pain after laparoscopic tubal ligation. Anesth Analg. 1991;73:112–118
- . The efficacy of dexmedetomidine versus morphine for postoperative analgesia after major inpatient surgery. Anesth Analg. 2004;98:153–158
- . Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care. 2000;4:302–308
- . Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes. Anesthesiology. 1992;77:1134–1142
- . Hemodynamic and respiratory changes following dexmedetomidine administration during general anesthesia: sevoflurane vs desflurane. Paediatr Anaesth. 2007;17:438–444
- . Loss of transcranial electric motor evoked potentials during pediatric spine surgery with dexmedetomidine. Anesthesiology. 2007;106:393–396
- . A critical review of visual analogue scales in the measurement of clinical phenomena. Res Nurs Health. 1990;13:227–236
- . A hypnotic response to dexmedetomidine, an alpha 2 agonist, is mediated in the locus coeruleus in rats. Anesthesiology. 1992;76:948–952
- . The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects. Anesthesiology. 2003;98:428–436
- . CYP3A activity in African American and European American men: population differences and functional effect of the CYP3A4⁎1B5′-promoter region polymorphism. Clin Pharmacol Ther. 2000;68:82–91
- . Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate. Anesthesiology. 1992;77:1125–1133
- Use of dexmedetomidine in children after cardiac and thoracic surgery. Pediatr Crit Care Med. 2006;7:126–131
- . Initial experience with dexmedetomidine in paediatric-aged patients. Paediatr Anaesth. 2002;12:171–175
- Neuroprotection by the alpha2-adrenoceptor agonist, dexmedetomidine, in rat focal cerebral ischemia. Eur J Pharmacol. 1999;372:31–36
- . Preservation of the cortical somatosensory-evoked potential during dexmedetomidine infusion in rats. Anesth Analg. 2003;96:1155–1160
- . The effect of intravenous dexmedetomidine premedication on the dose requirement of propofol to induce loss of consciousness in patients receiving alfentanil. Anaesthesia. 2001;56:408–413
- . Dexmedetomidine and cardiac arrest. Anesthesiology. 2004;100:738–739
- . Central apnoea after balanced general anaesthesia that included dexmedetomidine. Br J Anaesth. 2005;95:773–775
- . Sedation during mechanical ventilation in infants and children: dexmedetomidine versus midazolam. South Med J. 2004;97:451–455
- . Short duration large dose dexmedetomidine in a pediatric patient during procedural sedation. Anesth Analg. 2006;103:68–69
PII: S0952-8180(09)00254-2
doi: 10.1016/j.jclinane.2008.12.017
© 2009 Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Clinical Anesthesia
Volume 21, Issue 7
, Pages 493-501
, November 2009
